Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Evaluation of Peptide Immunization and LMB-2 in Metastatic Melanoma

NCT00295958 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00295958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Evaluation of Peptide Immunization and LMB-2 in Metastatic Melanoma
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
July 31, 2008
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin), non-melanomatous skin cancer